Takeda Recognized in the 2019 Dow Jones Sustainability World Index

Takeda Pharmaceutical Company Limited (“Takeda”) (TOKYO:4502/NYSE:TAK) today announced that it has been named in the 2019 Dow Jones Sustainability World Index, achieving more than double the average overall industry score. In addition, Takeda was named for the 10th consecutive year in the Dow Jones Sustainability Asia Pacific Index. The Dow Jones Sustainability Indices are an independent indication of the Company’s strong corporate environmental, social and governance (ESG) performance.

“Takeda’s commitment to creating and preserving value through environmental, social and governance initiatives is an important part of our role as a patient-centric and values-based global biopharmaceutical leader,” said Christophe Weber, President and CEO. “We understand the significance of sustainable business practices, and we are proud to be recognized for Takeda’s global impact and long-term commitment to building a brighter future.”

Takeda achieved more than double the average pharmaceutical industry sustainability score. Its strong scores in climate strategy and eco-efficiency support Takeda’s approach that a proactive environmental program focused on reducing environmental impacts leads to tangible economic benefits. Takeda also achieved double-digit year-over-year growth in its score for access to medicines – more than triple the industry average – based on its strategies to help strengthen evolving healthcare systems and tackle barriers that limit patient access.

In addition to Dow Jones World and Asia Pacific Indices, Takeda has been selected by multiple benchmark ESG indices and recognitions:

Name of Index or Rating	Company/ Organization	Country	History of Inclusion
FTSE4Good Developed Index	FTSE Russell	UK	15th consecutive year
MSCI ESG Leaders Index	MSCI	U.S.	10th consecutive year
Ethibel EXCELLENCE Investment Register	Forum Ethibel	BEL	From July 2017
Prime Status